Literature DB >> 28025065

Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries.

Frederick A Masoudi1, Angelo Ponirakis2, James A de Lemos3, James G Jollis4, Mark Kremers5, John C Messenger6, John W M Moore7, Issam Moussa8, William J Oetgen2, Paul D Varosy9, Robert N Vincent10, Jessica Wei2, Jeptha P Curtis11, Matthew T Roe12, John A Spertus13.   

Abstract

Cardiovascular disease is a leading cause of death and disability in the United States. National programs, such as the National Cardiovascular Data Registry, facilitate assessments of the quality of care and outcomes for broad populations of patients with cardiovascular disease. This report provides data for 2014 from 4 National Cardiovascular Data Registry hospital quality programs: 1) CathPCI (Diagnostic Catheterization and Percutaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervention (667,424 procedures performed in 1,612 hospitals); 2) ICD Registry for implantable cardioverter-defibrillators (158,649 procedures performed in 1,715 hospitals); 3) ACTION-GWTG (Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines) for acute coronary syndromes (182,903 patients admitted to 907 hospitals); and 4) IMPACT (Improving Pediatric and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric and adult congenital heart disease (20,169 procedures in 76 hospitals). The report provides perspectives on the demographic and clinical characteristics of enrolled patients, characteristics of participating centers, and selected measures of processes and outcomes of care in these programs.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute coronary syndromes; congenital heart disease; implantable cardioverter-defibrillators; percutaneous coronary intervention; quality of care

Mesh:

Year:  2016        PMID: 28025065     DOI: 10.1016/j.jacc.2016.12.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  53 in total

Review 1.  Revascularization Strategies for Non-ST-Elevation Myocardial Infarction.

Authors:  Bennet George; Naoki Misumida; Khaled M Ziada
Journal:  Curr Cardiol Rep       Date:  2019-04-10       Impact factor: 2.931

Review 2.  Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.

Authors:  Peter Libby
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

Review 3.  From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research.

Authors:  José M de la Torre Hernández; Elazer R Edelman
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-08-31

Review 4.  Metabolic Stress.

Authors:  Isabella M Grumbach; Emily K Nguyen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

5.  Association of State Medicaid Expansion With Quality of Care and Outcomes for Low-Income Patients Hospitalized With Acute Myocardial Infarction.

Authors:  Rishi K Wadhera; Deepak L Bhatt; Tracy Y Wang; Di Lu; Joseph Lucas; Jose F Figueroa; Kirk N Garratt; Robert W Yeh; Karen E Joynt Maddox
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

6.  Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.

Authors:  Jason H Wasfy; Kevin F Kennedy; Frederick A Masoudi; Timothy G Ferris; Suzanne V Arnold; Vinay Kini; Pamela Peterson; Jeptha P Curtis; Amit P Amin; Steven M Bradley; William J French; John Messenger; P Michael Ho; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-09

7.  Does acute kidney disease following primary percutaneous coronary intervention lead to chronic kidney disease development and progression?

Authors:  Etienne Macedo; Ravindra L Mehta
Journal:  Coron Artery Dis       Date:  2019-03       Impact factor: 1.439

Review 8.  Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.

Authors:  George W Vetrovec
Journal:  Curr Cardiol Rep       Date:  2017-08-31       Impact factor: 2.931

9.  Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial.

Authors:  Mark D Huffman; Padinhare P Mohanan; Raji Devarajan; Abigail S Baldridge; Dimple Kondal; Lihui Zhao; Mumtaj Ali; Mangalath N Krishnan; Syam Natesan; Rajesh Gopinath; Sunitha Viswanathan; Joseph Stigi; Johny Joseph; Somanathan Chozhakkat; Donald M Lloyd-Jones; Dorairaj Prabhakaran
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

10.  Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.

Authors:  Chirag Bavishi; Alejandro Lemor; Vrinda Trivedi; Saurav Chatterjee; Pedro Moreno; John Lasala; Herbert D Aronow; J Dawn Abbott
Journal:  Clin Cardiol       Date:  2018-04-26       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.